Development and validation of an extraction method for the determination of pro-inflammatory eicosanoids in human plasma using liquid chromatography–tandem mass spectrometry
Authors:
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1353, 57-64
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Association of Leukotriene Gene Variants and Plasma LTB4 Levels with Coronary Artery Disease in Asian IndiansISRN Vascular Medicine, 2013
- Circulating Leukotriene B4 Identifies Respiratory Complications after TraumaMediators of Inflammation, 2012
- Development and validation of an on‐line two‐dimensional reversed‐phase liquid chromatography–tandem mass spectrometry method for the simultaneous determination of prostaglandins E2 and F2α and 13,14‐dihydro‐15‐keto prostaglandin F2α levels in human plasmaBiomedical Chromatography, 2008
- Inverse correlation between serum PGE2 and T classification in head and neck cancerHead & Neck, 2007
- Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatmentEuropean journal of pain, 2006
- Cyclooxygenase-2: a potential target in breast cancerSeminars in Oncology, 2004
- Leukotriene A4 Hydrolase in Rat and Human Esophageal Adenocarcinomas and Inhibitory Effects of BestatinJNCI: Journal of the National Cancer Institute, 2003
- Prostaglandin E2 levels in blood plasma and in crevicular fluid of advanced periodontitis patients before and after surgical therapyOral Diseases, 1999
- Plasma Endothelin-1, Cytokine, and Prostaglandin E2Levels in Sickle Cell Disease and Acute Vaso-Occlusive Sickle CrisisBlood, 1998
- A highly sensitive and selective method for the determination of Leukotriene B4 in human plasma by negative ion chemical ionization/gas chromatography/tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 1995